medigraphic.com

2004, Number s3

Arch Cardiol Mex 2004; 74 (s3)

Diagnosis, stratification and treatment of the acute pulmonary thromboembolism. Guidance and Recommendations of the Pulmonary Circulation chapter from the Mexican Society of Cardiology

Jerjes-Sánchez DC, Elizalde GJJ, Sandoval ZJ, Gutiérrez-Fajardo P, García León MS, Ramírez-Rivera A, Pulido T, Beltrán M, Santos E, Bautista E, Ibarra-Pérez C, Arriaga-Nava R.

Language: Spanish
References: 225
Page: 547-585
PDF size: 347.09 Kb.


Text Extraction

No abstract


REFERENCES

  1. Task Force on Pulmonary Embolism, European Society Cardiology: Guidelines on diagnosis and management of acute pulmonary embolism. Eur Heart J 2000; 21: 1301-1336.

  2. Wood KE: Major pulmonary embolism. Chest 2002; 121: 877-905.

  3. Delgado-Brambila H, Jiménez CC, García PG: Trombosis venosa profunda consecutiva a cirugía de cadera y de la rodilla: determinación de su incidencia. Rev Mex Ortopedia 1993; 7: 195-198.

  4. Sigler L, Romero T, Meillón LA, Gutiérrez L, Aguirre GJ, Esparza C: Tromboembolia pulmonar en autopsias en un período de 10 años. Rev Med IMSS 1996; 34: 7-11.

  5. Sandoval ZJ, Martínez GML, Gómez A, Palomar A, Pulido T, Zevallos M, et al: La magnitud del problema. En: Julio Sandoval. Tromboembolia pulmonar aguda. México DF. PLAC Cardio-1 de la Sociedad Mexicana de Cardiología. Intersistemas, S.A. de C.V., 1998, p. 7-9

  6. Ramirez-Rivera A, Gutierrez-Fajardo P, Jerjes-Sanchez C, Hernandez-Chavez G: Acute right myocardial infarction without significant obstructive coronary lesions secondary to massive pulmonary embolism. Chest 1993; 104: 80S.

  7. Otero G, Otero F: Análisis de los egresos hospitalarios por enfermedades venosas. MIM 1996; 12: 152-158.

  8. Kasper W, Konstantinides S, Geibel A, Olschewski M, Heinrich F, Grosser KD, et al: Management strategies and determinants of outcome in acute major pulmonary embolism: results of a multicenter registry. J Am Coll Cardiol 1997; 30: 1165-1171.

  9. Goldhaber SZ, Visani L, De Rosa M: Acute pulmonary embolism; clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet 1999; 353: 1386-1389.

  10. Jerjes-Sánchez C, Ramírez-Rivera A, Gutiérrez-Fajardo P, García-Castillo A, Cantú DF, Treviño OH, Villarreal GI: Un enfoque diferente del estado actual de la trombólisis en tromboembolia pulmonar. Arch Inst Cardiol Mex 1998; 68: 166-180.

  11. Stein PD, Henry JW: Prevalence of acute pulmonary embolism among patients in a general hospital and at autopsy. Chest 1995; 108: 78-81.

  12. Mopurgo M, Schmid C: Clinico-phatologic correlations in pulmonary embolism: a posteriori evaluation. Prog Resp Dis 1980; 13: 8-15.

  13. Goldhaber SZ: Strategies for diagnosis. In: Goldhaber SZ, ed. Pulmonary Embolism and Deep Vein Thrombosis. Philadelphia: Saunders, 1985, p.79-97.

  14. Rubinstein I, Murray D, Hoffstein V: Fatal pulmonary emboli in hospitalized patients. An autopsy study. Arch Intern Med 1988; 148:1425-1426

  15. Gross JS, Neufeld RR, Libow LS, Gerber I, Rodstein M: Autopsy study of the elderly institutionalized patient. Review of 234 autopsies. Arch Intern Med 1988; 148:173-176

  16. Mandelli V, Schmid C, Zogno C: False negatives and false positives in acute pulmonary embolism. A clinical postmorten comparison. Cardiologia 1997; 42: 205-210.

  17. Morpurgo M, Schmid C. Mandelli V: Factors influencing the clinical diagnosis of pulmonary embolism: analysis of 229 postmortem cases. Int J Cardiol 1998; 65: S79-S82.

  18. Jerjes-Sánchez C, Ramírez-Rivera A, Ibarra PC, Colmenero SZ: Tromboembolia pulmonar en niños. Arch Inst Cardiol Mex 1991; 61: 445-449.

  19. Jerjes-Sánchez C, Ramírez-Rivera A: ¿Qué de nuevo de la tan antigua tromboembolia pulmonar? (I Parte). Arch Inst Cardiol Mex 1992; 62: 95-99.

  20. Goldhaber SZ, Grodstein F, Stampfer MJ: A prospective study of risk factors for pulmonary embolism in women. JAMA 1997; 277: 642-645.

  21. Bok YHH, de Paiva SAR, Silveira LVA, Queluz TT: Logistic regression analysis of potential prognostic factors for pulmonary thromboembolism. Chest 2003; 123: 813-821.

  22. Goldhaber SZ: Overview of pulmonary embolism. In: Pulmonary Embolism. T. Nakano, Goldhaber SZ, eds. Sokosha, Japan. Tokyo Ed. Springer-Verlag 1999, p. 3-18

  23. Toglia MR, Weg JG: Venous thromboembolism during pregnancy. N Engl J Med 1996; 335:108-113.

  24. Giuntini C, Di Ricco G, Marini C: Epidemology. Chest 1995; 107 (Suppl I): 3S-9S.

  25. Blann AD, Landray MJ, Lip GYH: An overview of antithrombotic therapy. BMJ 2002; 325: 762-765.

  26. Carson JL: The clinical course of pulmonary embolism. N Engl J Med 1992; 326: 1240-1245.

  27. Chiche P: La maladie thromboembolique pulmonaire. Paris: L’ Expansion Scientifique Française, 1969 (citado por Morpurgo M, Marzegalli M. Death in pulmonary embolism. In: Pulmonary Embolism. Morpurgo M. ed. New York Marcel Dekker, 1994, p. 107-114.

  28. Moser KM: Venous thromboembolism. Am Rev Respir Dis 1990; 141: 235-249.

  29. Riveiro A, Lindmarker P, Juhlin-Dannfelt A, Johnson H, Jorfeldt L: Echocardiography Doppler in pulmonary embolism: right ventricular dysfunction as predictor of mortality. Am Heart J 1997; 134: 479-478.

  30. Kasper W, Konstantinides S, Geibel A: Prognostic significance of right ventricular afterload stress detected by echocardiography in patients with clinical suspected pulmonary embolism. Heart 1997; 77: 346-349.

  31. Jerjes-Sanchez C, Ramirez-Rivera A, Garcia ML, Arriaga-Nava R, Valencia-Sanchez S, Rosado-Buzzo A, et al: Streptokinase and heparin vs heparin alone in massive pulmonary embolism: A randomized controlled trial. J Thromb Thrombolysis 1995; 2: 67-69.

  32. Jerjes-Sanchez C, Ramirez-Rivera A, Arriaga-Nava R, Iglesias-Gonzalez S, Gutierrez P, Ibarra-Perez C, et al: High dose and short-term streptokinase infusion in patients with pulmonary embolism. Prospective with seven-year follow-up trial. J Thromb Thrombolysis 2001; 12: 237-247.

  33. Riveiro A, Lindmarker P, Johnson H, Juhlin-Dannfelt A, Jorfeldt L: Pulmonary embolism: one year follow-up with echocardiography Doppler and five-year survival analysis. Circulation 1999; 99: 1325-1330.

  34. Konstantinides S, Geibel A, Kasper W, Olschewski M, Blumel L, Just H: Patent foramen ovale is an important predictor of adverse outcome in patients with major pulmonary embolism. Circulation 1998; 97: 1946-1951.

  35. Chartier L, Bera J, Delomez M, Asseman P, Beregi JP, Bauchard JJ, et al: Free-floating thrombi in the right heart: diagnosis, management and prognostic indexes in 38 consecutive patients. Circulation 1999; 99: 2779-2783.

  36. Jerjes-Sanchez C, Gutierrez-Fajardo P, Ramirez-Rivera A, Vargas-Barron J, Espindola-Zavaleta N, Romero-Cardenas A, et al: Pulmonary embolism and thrombus in transit. Multicenter trial. Thromb Haemost 2001; 86: 1S

  37. Ardissino D, Merlini PA, Eisenberg RP: Coagulation markers and outcomes in acute coronary syndromes. Am Heart J 1998; 136: S7-19.

  38. Rosendal FR: Venous thrombosis: a multicausal disease. Lancet 1999; 353: 1167-1173.

  39. Brown NJ, Vaughan DE: The renin-angiotensin and fibrinolytic systems. Trends Cardiovasc Med 1996; 6: 239-243.

  40. Schafer AI: Hypercoagulable states: molecular genetics to clinical practice. Lancet 1994; 344: 1739-1742.

  41. Pradoni P, Bilora F, Marchiori A, Bernardi E, Petrobelli F, Lensing AWA: An association between atherosclerosis and venous thrombosis. N Engl J Med 2003; 383: 1435-1441.

  42. Iftikhar K, Gerald G, Jamil TA: Novel risk factor for atherosclerosis. Mayo Clin Proc 2000; 75: 369-380.

  43. Macaulay O: Inherited thrombophilia, hypercoagulabilty and risk factors for atherosclerosis. Mayo Clin Proc 2000; 75: 870-871.

  44. Sakata T, Kario K, Katayama Y, Matsuyama T, Kato H, Miyata T, et al: Analysis of 45 episodes of arterial occlusive disease in Japanese patients with congenital protein C deficiency. Thromb Res 1999; 94: 69-78.

  45. Evans SM, Brittenden J, Adam DJ, Ludlam C, Bradbury AW: Prevalence and significance of thrombophilia in patients with intermittent claudication. Br J Surg 1999; 86: 702-703.

  46. Strater R, Vielhaver H, Kassenbohmer R, von Kries R, Gobel U, Nowak-Gottel U: Genetic risk factors of thrombophilia in ischaemic childhood stroke of cardiac origin: a prospective ESPED survey. Eur Pediatr 1999; 158 (suppl 3): S122-S125.

  47. Koh S, Chen LS: Protein C deficiency in children with ischemic cerebrovascular accident. Pediatr Neurol 1997; 319: 319-321.

  48. Sobieszczyk P, Fishbein MC, Goldhaber SZ: Acute pulmonary embolism. Do not ignore the platelet. Circulation 2002; 106: 1748-1749.

  49. Lualdi JC, Goldhaber SZ: Right ventricular dysfunction after acute pulmonary embolism: Phatophysiologic factors, detection, and therapeutic implications. Am Heart J 1995; 130: 1276-1282.

  50. Jerjes-Sanchez C, Comparan Al, Ibarra M, Decanini H: Interaction between haemostatic and inflammatory factors for increasing rate of adverse events in patients with acute coronary syndromes. Chest 2002; 122: 177S.

  51. Parcero JJ, Jerjes-Sánchez C, Ramírez RA, González CVM: Análisis hemodinámico de 60 casos de tromboembolia pulmonar. Arch Inst Cardiol Mex 1987; 57: 461S.

  52. Goldhaber SA: Thrombolysis for pulmonary embolism. Prog Cardiovas Dis 1991; 2: 113-114.

  53. Vlahakes GJ, Turley K, Hoffman JIE: Ischemia is a mechanism for right ventricular failure. Circulation 1979; 59/60 (suppl II): 256-259.

  54. Fixler DE, Archie JP, Ullyot DJ, Buckberg GD, Hoffman JIE: Effects of acute right ventricular systolic hypertension on regional myocardial blood flow in anesthetized dogs. Am Heart J 1973; 85: 491-500.

  55. Jerjes-Sánchez C, Gutiérrez-Fajardo P, Ramírez-Rivera A García ML, Hernández CHG: Infarto agudo del miocardio ventrículo derecho secundario a tromboembolia pulmonar masiva. Arch Inst Cardiol Mex 1995; 65: 65-73.

  56. Sandoval ZJ, Martínez GML, Gómez A, Palomar A, Pulido T, Zevallos M, et al: Fisiopatología y cuadro clínico de TEP aguda. En: Julio Sandoval. Tromboembolia pulmonar aguda. México DF. PLAC Cardio-1 de la Sociedad Mexicana de Cardiología. Intersistemas, S.A. de C.V., 1998, p. 20-26.

  57. Leclerec JR: Natural history of venous thromboembolism. In: Leclerc JR, ed. Venous Thromboembolic Disorders. Philadelphia: Lea Febiger, 1991: 166-175.

  58. Barritt DW, Jordan SC: Clinical features of pulmonary embolism. Lancet 1961; 1: 729-732.

  59. Pacouret G, Alison D, Pottier JM: Free-floating thrombus and embolic risk in patients with angiographically confirmed proximal deep venous thrombosis. A prospective study. Arch Intern Med 1977; 157: 305-308.

  60. Widimiský J: Mechanisms in embolic pulmonary hypertension. In: Wagenvoort CA, Denolin H, eds. Pulmonary Circulation. Advances and Controversies. Amsterdam: Elsevier 1989, p. 75-86.

  61. Rose PS, Punjabi NM, Pearse DB: Treatment of right heart thromboembolic. Chest 2002; 121: 806-814.

  62. Klotz TA, Cohn LS, Zipser RD: Urinary excretion of thromboxane B2 in patients with venous thromboembolic disease. Chest 1984; 85: 329-335.

  63. Dalen JE, Haffajee CI, Alpert JS, Howe III JP, Ockene IS, Paraskos JA. Pulmonary embolism, pulmonary hemorrhage and pulmonary infarction. N Engl J Med 1977; 296: 1431-1435.

  64. Sharma GVRK, Folland ED, McIntyre KM, Sasahara AA: Long-term benefit of thrombolytic therapy in patients with pulmonary embolism. Vascular Med 2000; 5: 91-95.

  65. Picott Leçons de Clinique Médicale 1884. Citado por la referencia 2.

  66. Ibarra-Pérez C: Tromboembolia pulmonar. Neumol Cir Tórax Mex 1978; 39: 169-184.

  67. Moser KM: Pulmonary embolism. Am Rev Respir Dis 1977; 115: 829-852.

  68. Goldhaber SZ: Pulmonary embolism thrombolysis improves survival in massive pulmonary embolism. J Thromb Thrombolysis 1995; 2: 59.

  69. Konstantinides S, Geibel A, Heusel G, Heinrich F, Kasper W: Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism. N Engl J Med 2002; 347: 1143-1150.

  70. Kucher N, Luder CM, Dörnhöfer T, Windecker S, Meir B, Hess OM: Novel management strategy for patients with suspected pulmonary embolism. Eur Heart J 2003; 24: 366-376.

  71. Goldhaber SZ: Advances in treating pulmonary embolism. Primary Cardiol 1994; 20: 15-20.

  72. Konstantinides S, Geibel A, Olschewski M, Kasper W, Hruska N, Jäckle S, et al: Importance of cardiac troponins I and T in risk stratification of patients with acute pulmonary embolism. Circulation 2002; 106: 1263-1268.

  73. Kucher N, Printzen G, Goldhaber SZ: Prognostic role of brain natriuretic peptide in acute pulmonary embolism. Circulation 2003; 107: 2545-2547.

  74. Garcia ML, Jerjes-Sanchez C, Ramirez-Rivera A, Arriaga-Nava R. Strategy in non-invasive diagnosis of pulmonary embolism for thrombolytic therapy. Chest 1994; 106: 122S.

  75. Tames MD, Alpert JS, Dalen JE. Syncope in patients with pulmonary embolism. JAMA 1977; 238: 2509-2511.

  76. Miller GA, Sutton GC: Acute massive pulmonary embolism: clinical and haemodynamic findings en 23 patients studied by cardiac catheterization and pulmonary angiography. Br Heart J 1970; 32: 518-523.

  77. Stein PD: The history and physical examination in patients with no prior cardiopulmonary disease: pulmonary embolism. Baltimore, MD: Williams and Wilkins, 1996, p. 41-53.

  78. Jerjes-Sánchez C, Ramírez RA, González CVM, García CA: Tromboembolia pulmonar masiva con desviación del eje eléctrico a la izquierda y bajo voltaje. Reporte de un caso. Arch Inst Cardiol Mex 1987; 57: 301-305.

  79. Jerjes-Sánchez C, Ramírez RA: ¿Qué de nuevo de la tan antigua Tromboembolia Pulmonar? (II parte). Arch Inst Cardiol Mex 1992; 62: 179-184.

  80. Jerjes-Sanchez C, Ramirez-Rivera A, Ibarra-Perez C: Pulmonary embolism and bradycardia. Intercontinental Cardiology 1996; 5: 27-29.

  81. Jerjes-Sanchez C, Ibarra PC, Ramirez RA, Padua GA, Gonzalez CVM: Dressler like syndrome after pulmonary embolism and infarction. Chest 1987; 92: 115-117.

  82. Jerjes-Sanchez C, Ramirez-Rivera A, Ibarra-Perez C: Dressler syndrome after pulmonary embolism. Am J Cardiol 1996; 78: 343-345.

  83. Ferrari E, Imbert A, Chevalier T, Milhoubi A, Morand P, Baudouny M: The ECG in pulmonary embolism. Predictive value of negative T waves in precordial leads–80 case reports. Chest 1997; 111: 537-543.

  84. Kucher N, Walpoth N, Wustmann K, Noveanu M, Gertsch M: QR in V1–an ECC sign associated with right ventricular strain and adverse clinical outcome in pulmonary embolism. Eur Heart J 2003; 24: 113-119.

  85. Reyes E, Jerjes-Sánchez C, Ramírez-Rivera A, Gutiérrez-Fajardo P, Garza A, Decanini H, Cantú F: Valor predictivo de qR asociado a desnivel positivo del segmento ST-T en V1 para el diagnóstico de infarto del ventrículo derecho secundario a TEP. Arch Inst Cardiol Mex 1997; 6: 148S.

  86. Palla A, Donnamaria V, Rossi G, Ricceti G, Giuntini C: Enlargement of the right descending pulmonary artery in pulmonary embolism. Am J Roentgenol 1983; 141: 513-517.

  87. Jerjes-Sanchez C, Ramirez-Rivera A, Ibarra-Perez C: Report of twenty-two cases of unilateral pulmonary edema. Intercontinental. Cardiology 1994; 3: 115-117.

  88. McIntyre KM, Sasahara AA: The hemodynamic response to pulmonary embolism in patients without prior cardiopulmonary disease. Am J Cardiol 1971; 28: 288–294.

  89. Miron MJ, Perrier A, Bounameaux H: Contribution of noninvasive evaluation to the diagnosis of pulmonary embolism in hospitalized patients. Eur Respir J 1999; 13: 1365–1370.

  90. Ginsberg JS, Wells PS, Kearon C: Sensitivity and specificity of a rapid whole-blood assay for D-dimer in the diagnosis of pulmonary embolism. Ann Intern Med 1998; 129: 1006–1011.

  91. Perrier A, Desmarais S, Miron MJ: Noninvasive diagnosis of venous thromboembolism. Lancet 1999; 353: 190–195.

  92. Dunn KL, Wolf JP, PBA, Dorfman DM, Fitzpatrick P, Baker JL, Goldhaber SZ: Normal D-Dimer levels in emergency department patients suspected of acute pulmonary embolism. J Am Coll Cardiol 2002; 40: 1475–1478.

  93. López-Sendón J: Troponinas y otros marcadores de daño miocárdico. Mitos y realidades. Rev Esp Cardiol 2003; 56: 16-19.

  94. Meyer T, Binder L, Hruska N, Luthe H, Buchwald AB: Cardiac troponin I levation in acute pulmonary embolism is associated with right ventricular dysfunction. J Am Coll Cardiol 2000; 36: 1632–1636.

  95. Goldhaber SZ: Cardiac biomarkers in pulmonary embolism. Chest 2003; 123: 1782-1783.

  96. Douketis JD, Crowther MA, Stanton EB, Ginsberg JS: Elevated cardiac troponin levels in patients with submassive pulmonary embolism. Arch Intern Med 2002; 162: 79-81.

  97. Torbicki A, Kurzyna M, Kuca P, Fijalkowska A, Sikora J, Florczyk M, et al. Detectable serum cardiac troponin T as a marker of poor prognosis among patients with chronic precapillary pulmonary hypertension. Circulation 2003; 108: 844-848.

  98. Janata K, Anton H, Laggner AN, Müllner M: Cardiac troponin T in the severity assessment of patients with pulmonary embolism: cohort study. BMJ 2003; 326: 312-313.

  99. Giannitsis E, Müller-Bardorff M, Kurowski V, Weidtmann B, Wiegand U, Kampmann M: Independent prognostic value of cardiac troponin T in patients with confirmed pulmonary embolism. Circulation 2000; 102: 211–217.

  100. Prusky P, Bochowicz A, Torbicki A, Szulc M, Kurzyna M, Fijalkowska A, et al: Cardiac troponin t monitoring identifies high-risk group of normotensive patients with acute pulmonary embolism. Chest 2003; 123: 1947-1952.

  101. Post F, Voigtländer T, Peetz D, Mertens D, Hafner G, Meyer J: Cardiac troponin I is related to mortality in acute pulmonary embolism. Thromb Haemost 2001; 86: 120S.

  102. Horwich TB, Patel J, MacLellan R, Fonarow GC: Cardiac troponin I is associated with impaired hemodynamics progressive left ventricular dysfunction and increase mortality rates in advanced heart failure. Circulation 2003; 108: 833-838.

  103. Kucher N, Wallman D, Carone A, Windecker S, Meier B, Hess OM: Incremental prognostic value of troponin I and echocardiography in patients with acute pulmonary embolism. Eur Heart J 2003; 24:1447-1454.

  104. Coma–Canela I, Gamallo C, Onsurbe PM, Lopez–Sendon J: Acute right infarction secondary to massive pulmonary embolism. Eur Hear J 1988; 9: 534-540.

  105. Adams III JE, Siegel BA, Goldstein JA, Jaffe AS: Elevations of CK-MB following pulmonary embolism. A manifestation of occult right ventricular infarction. Chest 1992; 101: 1203-1206.

  106. Gold FL, Bache RJ: Transmural right ventricular blood flow during acute pulmonary artery hypertension in the sedated dog. Circ Res 1982; 51: 196-204.

  107. Kucher N, Printzen G, Doernhoefer T, Windecker S, Meier B, Hess OM: Low pro-brain natriuretic peptide levels predict benign clinical outcome in acute pulmonary embolism. Circulation 2003; 107: 1576-1578.

  108. Kucher N, Printzen G, Goldhaber SZ: Prognostic role of brain natriuretic peptide in acute pulmonary embolism. Circulation 2003; 107: 2545-2547.

  109. McConnel MV, Solomon SD, Rayan ME: Regional right ventricular dysfunction detected by echocardiography in acute pulmonary embolism. Am J Cardiol 1996; 78: 469-473.

  110. Goldhaber SZ: Echocardiography in the management of pulmonary embolism. Ann Inter Med 2002; 136: 691-700.

  111. Cannon C, Goldhaber SZ: Cardiovascular risk stratification in pulmonary embolism patients. Am J Cardiol 1996; 78: 1149–1151.

  112. Gutiérrez-Fajardo P, Jerjes-Sánchez DC: El papel del ecocardiograma en las urgencias cardiovasculares. En: Carlos Jerjes Sánchez-Díaz Autor y Editor. Aspectos selectos en urgencias cardiovasculares 2001”. 2ª Edición actualizada. México DF. Editorial Vesalio Difusión, 2001, p. 357-387.

  113. Wolfe MW, Lee RT, Feldstein ML, Parker JA, Come P, Goldhaber SZ: Prognostic significance right ventricular hypokinesis and perfusion lung scan defects in pulmonary embolism. Am Heart J 1994; 127: 1371-1375.

  114. Kelly J, Hunt BJ, Moody A: Magnetic resonance direct thrombus imaging a novel technique for imaging venous thromboemboli. Thromb Haemost 2003; 89: 773-782.

  115. The PIOPED Investigators: Value of the ventilation perfusion scan in acute pulmonary embolism. JAMA 1990; 263: 2753–2759.

  116. McNeil BJ, Holman BL, Adelstein SJ: The scintigraphic definition of pulmonary embolism. JAMA 1974; 227: 753-756.

  117. Hull RD, Hirsh J, Carter CJ: Diagnostic value of ventilation-perfusion lung scanning in patients with suspected pulmonary embolism. Chest 1985; 88: 819-828.

  118. Cheely R, McCartney WH, Perry JR: The role of noninvasive tests vs pulmonary angiography in the diagnosis of pulmonary embolism. Am J Med 1981; 70: 17–22.

  119. McBride K, LaMorte WW, Menzoian JO: Can ventilation perfusion scans accurately diagnose acute pulmonary embolism? Arch Surg 1986; 121: 754-1757.

  120. Hull RD, Raskob GE, Carter CJ: Pulmonary embolism in outpatients with pleuritic chest pain. Arch Intern Med 1988; 148: 838–844.

  121. Alderson PO, Biello DR, Sachariah KG, Siegel BA: Scintigraphic detection of pulmonary embolism in patients with obstructive pulmonary disease. Radiology 1981; 138: 661–666.

  122. Spies WG, Burstein SP, Dillehay GL, Vogelzang RL, Spies SM: Ventilation-perfusion scintigraphy in suspected pulmonary embolism: correlation with pulmonary angiography and refinement of criteria for interpretation. Radiology 1986; 159: 383–390.

  123. Gray HW, McKillop JH, Bessent RG, Fogelman I, Smith ML, Moran F: Lung scanning for pulmonary embolism: clinical and pulmonary angiographic correlations. Q J Med 1990; 77: 1135–1350.

  124. Consenso Mexicano sobre Enfermedad Tromboembólica venosa. Cirugía Cirujanos 2000; 68 (supl 6): S7-S30.

  125. The PISA-PED Investigators: Value of perfusion lung scan in the diagnosis of pulmonary embolism: results of the prospective study of acute pulmonary embolism diagnosis (PISA-PED). Am J Respir Crit Care Med 1996; 154: 1387–1393.

  126. Grollman JH, Gyepes MT, Helmer E: Transfemoral selective bilateral pulmonary arteriography with a pulmonary artery seeking catheter. Radiology 1970; 96: 102–104.

  127. Remy-Jardin M, Remy J, Wattinne L, Giraud F: Central pulmonary thromboembolism: diagnosis with spiral volumetric CT with single-breath-hold technique-comparison with pulmonary angiography. Radiology 1992; 185: 381–387.

  128. Teigen CL, Maus TP, Sheedy II PF, Johnson CM, Stanson AW, Welch TJ: Pulmonary embolism: diagnosis with electron-beam CT. Radiology 1993; 188: 839-845.

  129. Van Rossum AB, Pattynama PMT, Tjin A: Pulmonary embolism: Validation of spiral CT-angiography in 124 patients. Radiology 1996; 201: 467-470.

  130. Matheus MC, Sandoval JZ, Criales CJL, Martínez-Guerra ML, Pulido T, Palomar AL, et al: La tomografía computarizada helicoidal del tórax en el diagnóstico de la tromboembolia pulmonar crónica no resuelta. Arch Inst Cardiol Mex 2000; 70: 456-467.

  131. Remy-Jardin M, Remy J, Artaud D, Deschildre F, Duhamel A: Peripheral pulmonary arteries: Optimization of the spiral CT acquisition protocol. Radiology 1997; 204: 157–163.

  132. Coche EC, Mueller NL, Kim K, Wiggs B, Mayo J: Acute pulmonary embolism: ancillary findings at spiral CT. Radiology 1998; 207: 753–758.

  133. Remy-Jardin M, Remy J, Cauvain O, Petyt L, Wannebroucq J, Beregi JP: Diagnosis of central pulmonary embolism with helical CT: role of two-dimensional multiplanar reformations. Am J Roentgenol 1992; 165: 1131–1138.

  134. Anaya A, Jerjes-Sánchez C, Ortiz F, Arriaga R, Cuan V, García O, Martínez R: Utilidad del ecocardiograma transesofágico en el diagnóstico de tromboembolia pulmonar masiva y estado de choque. Arch Inst Cardiol Mex 1993; 61: 1S.

  135. Pruszczyk P, Torbicki A, Pacho R: Noninvasive diagnosis of suspected severe pulmonary embolism: transesophageal echocardiography vs spiral CT. Chest 1997; 112: 722–728.

  136. Gutierrez-Fajardo P, Jerjes-Sanchez C, Ramirez-Rivera A: Role of transesophageal echocardiography in diagnosis and stratification in massive or large pulmonary embolism. Chest 1999; 116: 263S.

  137. Jerjes-Sanchez C, Gutierrez-Fajardo P, Ramirez-Rivera A: Qualitative echocardiographic stratification in pulmonary embolism. Significance of inversion of diastolic right/left ventricles ratio. Chest 1998; 114: 392S.

  138. Jerjes-Sanchez C, Ramirez-Rivera A, Gutierrez-Fajardo P: The ECG role in the stratification of massive pulmonary embolism. Chest 1998; 114: 392S.

  139. Krivec B, Voga G, Zuran I: Diagnosis and treatment of shock due to massive pulmonary embolism: approach with transesophageal echocardiography and intrapulmonary thrombolysis. Chest 1997; 112: 1310–1316.

  140. Van der Wouw PA, Koster RW, Delemarre BJ: Diagnostic accuracy of transesophageal echocardiography during cardiopulmonary resuscitation. J Am Coll Cardiol 1997; 30: 780–783.

  141. Ibarra-Perez C, Lau-Cortes E, Colmenero-Zubiate S, Avila-Ceballos N, Fong JH, Sanchez-Martinez R, et al: Prevalence and prevention of deep venous thrombosis of the lower extremities in high risk pulmonary patients. Angiology 1988; 39: 505-513.

  142. Gómez I, Elizalde J, Jerjes-Sánchez C, Martínez J, Ramírez-Rivera A: Profilaxis del tromboembolismo venoso pulmonar con heparina de bajo peso molecular vs heparina no fraccionada en pacientes de alto riesgo. Arch Inst Cardiol Mex 1995; 65: 78S.

  143. Weitz J, Hudoba M, Massel D: Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but susceptible to inactivation by antithrombin III-independent inhibitors. J Clin Invest 1990; 86: 385-91.

  144. Hyers TM, Agnelli G, Hull RD, Weg JG, Morris TA, Samama M, Tapson V: Anti-thrombotic therapy for venous thromboembolic disease. Chest 1998; 114/5 (Suppl): 561S–78S.

  145. Raschke RA, Reilly BM, Guidry JR: The weight-based heparin dosing nomogram compared with a standard care nomogram a randomized controlled trial. Ann Intern Med 1993; 119: 874–881.

  146. Young E, Prins M, Levine MN, Hirsh J: Heparin binding to plasma proteins: an important mechanism for heparin resistance. Thromb Haemost 1992; 67: 639–643.

  147. Brandjes DPM, Heijboer H, Buller HR, de Rijk M, Jagt H, Ten Cate JW: Acenocoumarol and heparin compared with acenocoumarol alone in the initial treatment of proximal vein thrombosis. N Engl J Med 1992; 327: 1485–1489.

  148. Levine MN, Raskob G, Landerfeld S, Hirsh J: Hemorrhagic complications of anticoagulant treatments. Chest 1995; 108 (Suppl): 276S–290S.

  149. Hirsh J, Raschke R, Warkentin TE, Dalen JE, Deykin D, Poller J: Heparin: mechanism of action, pharmacokinetics, dosing considerations, monitoring efficacy and safety. Chest 1995; 108 (Suppl): 258S–275S.

  150. The Columbus investigators. Low-molecular-weight heparin in the treatment of patients with venous thromboembolism. N Engl J Med 1997; 337: 657–662.

  151. Simonneau G, Sors H, Charbonnier B: A comparison of low-molecular-weight heparin with unfractionated heparin for acute pulmonary embolism. N Engl J Med 1997; 337: 663–669.

  152. Izaguirre AR, de la Peña DA: Perfil de las heparinas de bajo peso molecular. En: Siegler L, Castañeda R, Athie J. Trombosis venosa profunda y embolia pulmonar”. Eds. 1era Edición. México D.F. Editorial McGraw-Hill Interamericana SA. p. 233-250

  153. Thomson AJ, Walker ID, Greer IA: Low molecular weight heparins for immediate management of thromboembolic disease in pregnancy. Lancet 1998; 352: 1904-1908.

  154. Prandoni P, Lensing AWA, Cogo A: The long term clinical course of acute deep venous thrombosis. Ann Intern Med 1996; 125: 1–7.

  155. Hirsch J, Dalen JE, Anderson DR: Oral anticoagulants. Mechanism of action, clinical effectiveness and optimal therapeutic range. Chest 1998; 114/5 (Suppl): 445S–469S.

  156. Harrison L, Johnston M, Massicotte MP: Comparison of 5 mg and 10 mg loading doses in initiation of warfarin therapy. Ann Intern Med 1997; 126: 133–136.

  157. Hull RD, Hirsh J, Jay R: Different intensities of oral anticoagulant therapy in the treatment of proximal vein thrombosis. N Engl J Med 1982; 307: 1676–1681.

  158. Levine MN, Hirsh J, Gent M: Optimal duration of oral anticoagulant therapy. A randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis. Thromb Haemost 1995; 74: 606–611.

  159. Prandoni P, Lensing AWA, Büller HR: Deep vein thrombosis and the incidence of subsequent symptomatic cancer. N Engl J Med 1992; 327: 1128–1133.

  160. Schulman S, Rhedin AS, Lindmarker P: A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. N Engl J Med 1995; 332: 1661–1665.

  161. Ridker PM, Goldhaber SZ, Danielson E, Rosenberg Y, Eby CS, Deitcher SR, for the PREVENT: Investigators. Long term, low intensity warfarin for the prevention of recurrent venous thromboembolism. N Engl J Med 2003; 348: 1425-1434.

  162. Kearon C, Ginsberg JS, Kovacs MJ, Anderson DR, Wells P, Julian JA, et al: Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism. N Engl J Med 2003; 349: 631-639.

  163. Crowther MA, Donovan D, Harrison L: Low dose oral vitamin K reliably reverses over-anticoagulation due to warfarin. Thromb Haemost 1998; 79: 1116–1118.

  164. Grimaudo V, Gueissaz F, Hauert J: Necrosis of skin induced by coumarin in a patient deficient in protein S. Br Med J 1989; 298: 233–234.

  165. Sanson BJ, Lensing AWA, Prinz MH: Safety of low molecular weight heparin in pregnancy: a systematic review. Thromb Haemost 1999; 81: 668–672.

  166. Thery C, Asseman P, Amrouni N: Use of a new removable vena cava filter in order to prevent pulmonary embolism in patients submitted to thrombolysis. Eur Heart J 1990; 11: 334–341.

  167. Bovyn G, Gory P, Reynaud P, Ricco JB: The tempofilterR: a multicenter study of a new temporary caval filter implantable for up to six weeks. Ann Vasc Surg 1997; 11: 520–528.

  168. Greenfield LJ, Cho KJ, Proctor M: Results of a multicenter study of the modified hook-titanium Greenfield filter. J Vasc Surg 1991; 14: 253–257.

  169. Ricco JB, Crochet D, Sebicotte P: Percutaneous transvenous caval interruption with the ‘LGM’ filter: early results of a multicenter trial. Ann Vasc Surg 1988; 2: 242–247.

  170. Simon M, Athanasoulis CA, Kim D: Simon Nitinol inferior vena cava filter: initial clinical experience. Radiology 1989; 172: 99–103.

  171. Roehm JOF Jr: The Bird’s nest filter: a new percutaneous transcatheter inferior vena cava filter. J Vasc Surg 1984; 1: 498–501.

  172. Greenfield LJ, Cho KJ, Proctor M, Sobel M, Sham S, Wingo J: Late results of supra-renal Greenfield filter placement. Arch Surg 1992; 127: 969–973.

  173. Stewart JR, Peyton JWR, Crute LL, Greenfield LJ: Clinical results of suprarenal placement of the Greenfield vena cava filter. Surgery 1982; 92: 1–4.

  174. Ballew KA, Philbrick JT, Becker DM: Vena cava filter devices. Clin Chest Med 1995; 16: 295–305.

  175. Decousus H, Leizorovicz A, Parent F. Page Y, Tardy B, Girard P, for the Prevention du Risque d’Embolie Pulmonaire par Interruption Cave Study Group: A clinical trial of vena cava filters with prevention of pulmonary embolism in patients with proximal deep vein thrombosis. N Engl J Med 1998; 338: 409–415.

  176. Becker DM, Philbrick JT, Selby JB: Inferior vena cava filters, indications, safety, effectiveness. Arch Intern Med 1992; 152: 1985–1994.

  177. Crochet DP, Stora O, Ferry D. White S: Vena Tech-LGM filter: long term results of a prospective study. Radiology 1993; 188: 857–860.

  178. White RH, Zhou H, Kim J, Romano PS: A population-based study of the effectiveness of inferior vena cava filters use among patients with venous thromboembolism. Arch Intern Med. 2000; 160: 2033-2041.

  179. Girard P, Stern JB, Parent F: Medical literature and vena cava filters. So far so weak. Chest 2002; 122: 963–967.

  180. Kolachalam RB, Julian TB: Clinical presentation of thrombosed Greenfield filters. Vasc Surg 1990; 9: 666–670.

  181. Castellani L, Nicaise M, Pietri J: Transvenous interruption of the inferior vena cava. Int Angiol 1987; 6: 299–306.

  182. Roehm JOF Jr, Johnsrude IS, Barth MH, Gianturco C: The Bird’s nest inferior vena cava filter: progress report. Radiology 1988; 168: 745–749.

  183. Dalla-Volta S, Palla A, Santolicandro A, PAIMS 2: Alteplase combined with heparin vs heparin in the treatment of acute pulmonary embolism. Plasminogen Activator Italian Multicenter Study 2. J Am Coll Cardiol 1992; 20: 520–526.

  184. Tibbutt DA, Davies JA, Anderson JA: Comparison by controlled clinical trial of streptokinase and heparin in treatment of life-threatening pulmonary embolism. Br Med J 1974; 1: 343–347.

  185. Goldhaber SZ, Haire WS, Feldstein ML: Alteplase vs heparin in acute pulmonary embolism; randomized trial assessing right-ventricular function and pulmonary perfusion. Lancet 1993; 341: 507-511.

  186. Jerjes-Sanchez C, Villarreal S, Ramirez-Rivera A, Arriaga R, Rangel F, Garcia A, et al: One hour alteplase infusion plus low molecular weight heparin vs heparin alone in pulmonary embolism. Eur Resp J 2003; 22: 563S.

  187. Meneaveu N, Ming LP, Seronde MF, Mersin N, Shiele F, Caulfield F, et al: In-hospital and long-term outcome after sub-massive and massive pulmonary embolism submitted to thrombolytic therapy. Eur Hear J 2003; 24: 1447-1454.

  188. Baker WF: Thrombolytic therapy: clinical applications. Hematology/oncology Clin North Amer 2003; 17: 1-25.

  189. Jerjes-Sánchez C, Ramírez RA, Arriaga NR, Pimentel MG: Dosis altas e infusión rápida de estreptoquinasa para el tratamiento de tromboembolia pulmonar masiva. Arch Inst Cardiol Mex 1993; 63: 227-234.

  190. Meyer G, Sors H, Charbonnier B: Effects of intravenous urokinase vs alteplase on total pulmonary resistance in acute massive pulmonary embolism: A European multicenter double-blind trial. J Am Coll Cardiol 1992; 19: 239–245.

  191. Sors H, Pacouret G, Azarian R, Meyer G, Charbonnier B, Bassand JP, Simonneau G: Hemodynamic effects of bolus vs two hour infusion of alteplase in acute massive pulmonary embolism. A randomized controlled multicenter trial. Chest 1994; 106: 712–717.

  192. Goldhaber SZ, Agnelli G, Levine MN: Reduced dose bolus alteplase vs conventional alteplase infusion for pulmonary embolism thrombolysis. An international multicenter randomized trial. Chest 1994; 106: 718–724.

  193. Meneveau N, Schiele F, Metz D: Comparative efficacy of a two hour regimen of streptokinase vs alteplase in acute massive pulmonary embolism: immediate clinical and hemodynamic outcome and one-year follow-up. J Am Coll Cardiol 1998; 32: 1057–1063.

  194. Konstantinides S, Geibel A, Heusel G, Heinrich F, Kasper W: Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism. N Engl J Med 2002; 347: 1143-1150.

  195. Tebbe U, Graft A, Kamke W, Zahn R, Forycki F, Kratzch G, et al: Hemodynamic effects of double bolus reteplase vs alteplase infusion in massive pulmonary embolism. Am Hear J 1999; 138: 39-44.

  196. Jerjes-Sanchez C, Gutierrez-Fajardo P, Ramirez-Rivera A, Treviño H, Villarreal I, Bermudez M, Garcia-Castillo A: Broadening thrombolytic therapy indications in patients with pulmonary embolism. Chest 1999; 116: 263S.

  197. Thabut G, Thabut D, Myers RP, Bernard-Chabert B, Marrash-Chahla R, Mal H, Fournier M: Thrombolytic therapy of pulmonary embolism. A meta-analysis. J Am Coll Cardiol 2002; 40: 1660–1667.

  198. Agnelli G, Becattini C, Kirschstein T: Thrombolysis vs heparin in the treatment of pulmonary embolism. A clinical outcome–based meta-analysis. Arch Intern Med 2002; 162: 2537-2541.

  199. Goldhaber ZS: Thrombolysis for pulmonary embolism. N Engl J Med 2002; 347: 131-132.

  200. García ML, Jerjes-Sánchez C: Trombólisis en tromboembolia pulmonar con hipertensión arterial pulmonar previa. Arch Inst Cardiol Mex 1993; 61: 1S.

  201. García MML, Jerjes-Sánchez C, Arriaga-Nava R, Valencia S, Ramírez-Rivera A: Reoclusión temprana y trombólisis de rescate en tromboembolia pulmonar. Arch Inst Cardiol Mex 1995; 65: 13S.

  202. Stein PD, Hull RD, Raskob G: Risks for major bleeding from thrombolytic therapy in patients with acute pulmonary embolism. Ann Intern Med 1994; 121: 313–317.

  203. Mikkola KM, Patel SR, Parker JA, Grodstein F, Goldhaber SZ: Increasing age is a major risk factor for hemorrhagic complications after pulmonary embolism thrombolysis. Am Heart J 1997; 134: 69–72.

  204. Meyer G, Charbonnier B, Stern M, Brochier M, Sors H: Thrombolysis in acute pulmonary embolism. In: Julian DG, Kubler W, Norris RM, Swan HJ, Collen D, Verstraete M, eds. Thrombolysis in cardiovascular disease. New-York, Marcel Dekker, 1989, p. 337–360.

  205. Meyer G, Gisselbrecht M, Diehl JL, Journois D, Sors H: Incidence and predictors of major hemorrhagic complications from thrombolytic therapy in patients with massive pulmonary embolism. Am J Med 1998; 105: 472–477.

  206. Urokinase Pulmonary Embolism Trial (UPET). A national cooperative study. Circulation 1973; 47 (Suppl II):1–130.

  207. Kanter DS, Mikkola KM, Patel SR, Parker JA, Goldhaber SZ: Thrombolytic therapy for pulmonary embolism. Frequency of intracranial hemorrhage and associated risk factors. Chest 1997; 111: 1241–1245.

  208. Elizalde J, Jerjes-Sanchez C, Ramirez-Rivera A, Franco J, Martinez-Sanchez J: High risk factors for bleeding complications in patients with thrombolytic therapy and massive pulmonary embolism. Chest 1994; 106: 123S.

  209. William Haire: Tratamiento de las complicaciones hemorrágicas en las urgencias cardiovasculares. Carlos Jerjes Sánchez-Díaz Autor y Editor. En: Aspectos selectos en urgencias cardiovasculares 2001. 2ª Edición actualizada. México DF. Editorial Vesalio Difusión, 2001, p. 169-179.

  210. Ahearn GS, Hadjiliadis D, Govert JA, Tapson VF: Massive pulmonary embolism during pregnancy successfully treated with recombinant tissue plasminogen activator: A case report and review of treatment options. Arch Intern Med 2002; 162: 1221-1227.

  211. The UKEP study: Multicenter clinical trial on two local regimens of urokinase in massive pulmonary embolism. Eur Heart J 1987; 8: 2–10.

  212. Pruszczyk P, Torbicki A, Pacho R: Noninvasive diagnosis of suspected severe pulmonary embolism: transesophageal echocardiography vs spiral CT. Chest 1997; 112: 722–8.

  213. Krivec B, Voga G, Zuran I: Diagnosis and treatment of shock due to massive pulmonary embolism: approach with transesophageal echocardiography and intrapulmonary thrombolysis. Chest 1997; 112: 1310–1316

  214. Vieillard-Baron A, Qanadli SD, Antakly Y: Transesophageal echocardiography for the diagnosis of pulmonary embolism with acute cor pulmonale: a comparison with radiological procedures. Intensive Care Med 1998; 24: 429–433.

  215. Bauer EP, Laske A, von Segesser L, Carrel T, Turina M: Early and late results after surgery for massive pulmonary embolism. Thorac Cardiovasc Surg 1991; 39: 353-356.

  216. Doerge HC, Schoendube FA, Loeser H, Walter M, Messmer BJ: Pulmonary embolectomy: review of a 15 year experience and role in the age of thrombolytic therapy: early and late results. Thorac Cardiovasc Surg 1999; 47: 9–13.

  217. Stulz P, Schläpfer R, Feer R, Habicht J, Grädel E: Decision making in the surgical treatment of massive pulmonary embolism. Eur J Cardio-Thorac Surg 1994; 8: 188–193.

  218. Mohan CR, Hoballah JJ, Sharp WJ, Kresowik TF, Lu CT, Corson JD: Comparative efficacy and complications of vena caval filters. J Vasc Surg 1995; 21: 235–246.

  219. Haire WD: Vena caval filters for the prevention of pulmonary embolism. N Engl J Med 1998; 338: 463–464.

  220. Meyer G, Tamisier D, Sors H: Pulmonary embolectomy: a 20 year experience at one center. Ann Thorac Surg 1991; 51: 232–236.

  221. Robinson RJ, Fehrenbacher J, Brown JW, Madura JA, King H: Emergent pulmonary embolectomy: the treatment for massive pulmonary embolus. Ann Thorac Surg 1986; 42: 52–55.

  222. Beall AC: Pulmonary embolectomy. Ann Thorac Surg 1991; 51: 179-185.

  223. Lishan Aklog L, Williams CS, Byrne JG, Goldhaber SZ: Acute pulmonary embolectomy. A contemporary approach. Circulation 2002; 105: 1416-1419.

  224. Greco F, Bisignani G, Serafini O, Guzzo D, Stingone A, Plastina F: Successful treatment of right heart thromboemboli with IV recombinant tissue–type activator during echocardiographic monitoring. A case series report. Chest 1999; 116: 78-82.

  225. Fedullo PF, Tapson VF: The evaluation of suspected pulmonary embolism. N Engl J Med 2003; 349: 1247-1256.




2020     |     www.medigraphic.com